Gelsomino, Francesco*; Vitale, Giovanni; Ardizzoni, Andrea, Immune-mediated cholangitis: is it always nivolumab’s fault?, «CANCER IMMUNOLOGY, IMMUNOTHERAPY», 2018, 67, pp. 1325 - 1327 [Scientific article]
Tiseo, Marcello*; Boni, Luca; Ardizzoni, Andrea, Is the door open to further investigation with antiangiogenesis in SCLC?, «JOURNAL OF THORACIC DISEASE», 2018, 10, pp. S1127 - S1128 [Scientific article]
Ghedini, Pietro*; Bossert, I.; Zanoni, L.; Ceci, F.; Graziani, T.; Castellucci, P.; Ambrosini, V.; Massari, F.; Nobili, E.; Melotti, B.; Musto, A.; Zoboli, S.; Antunovic, L.; Kirienko, M.; Chiti, A.; Mosconi, C.; Ardizzoni, A.; Golfieri, R.; Fanti, S.; Nanni, C., Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2018, 45, pp. 751 - 758 [Scientific article]
Mazzaschi, Giulia; Madeddu, Denise; Falco, Angela; Bocchialini, Giovanni; Goldoni, Matteo; Sogni, Francesco; Armani, Giovanna; Lagrasta, Costanza Annamaria; Lorusso, Bruno; Mangiaracina, Chiara; Vilella, Rocchina; Frati, Caterina; Alfieri, Roberta; Ampollini, Luca; Veneziani, Michele; Silini, Enrico Maria; Ardizzoni, Andrea; Urbanek, Konrad; Aversa, Franco; Quaini, Federico*; Tiseo, Marcello, Low PD-1 expression in cytotoxic CD8þtumor-Infiltrating lymphocytes confers an immune-privileged tissue microenvironment in NSCLC with a prognostic and predictive value, «CLINICAL CANCER RESEARCH», 2018, 24, pp. 407 - 419 [Scientific article]
Garassino, Marina Chiara; Crinò, Lucio; Catino, Annamaria; Ardizzoni, Andrea; Cortesi, Enrico; Cappuzzo, Federico; Bordi, Paola; Calabrò, Luana; Barbieri, Fausto; Santo, Antonio; Altavilla, Giuseppe; Ambrosio, Francesca; Mini, Enrico; Vasile, Enrico; Morgillo, Floriana; Scoppola, Alessandro; Bengala, Carmelo; Follador, Alessandro; Tedde, Natale; Giannarelli, Diana; Lo Russo, Giuseppe*; Vitiello, Fabiana, Nivolumab in never-smokers with advanced squamous non-small cell lung cancer: Results from the Italian cohort of an expanded access program, «TUMOR BIOLOGY», 2018, 40, pp. 1 - 8 [Scientific article]Open Access
Comito, Francesca; Ambrosini, Valentina; Sperandi, Francesca; Melotti, Barbara; Ardizzoni, Andrea, Osteoblastic bone response mimicking bone progression during treatment with pembrolizumab in advanced cutaneous melanoma, «ANTI-CANCER DRUGS», 2018, 29, pp. 1026 - 1029 [Scientific article]
Gelsomino, F.; Fiorentino, M.*; Zompatori, M.; Poerio, A.; Melotti, B.; Sperandi, F.; Gargiulo, M.; Borghi, C.; Ardizzoni, A., Programmed death-1 inhibition and atherosclerosis: Can nivolumab vanish complicated atheromatous plaques?, «ANNALS OF ONCOLOGY», 2018, 29, Article number: mdx718 , pp. 284 - 285 [Scientific article]
Massari F.; Di Nunno V.; Ardizzoni A., Re: Robert J. Motzer, Alain Ravaud, Jean-Jacques Patard, et al. Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results. Eur Urol 2018;73:62–8, «EUROPEAN UROLOGY», 2018, 73, pp. 72 - 72 [Scientific article]
Massari F, Di Nunno V, Gatto L, Santoni M, Schiavina R, Cosmai L, Brunocilla E, Ardizzoni A, Porta C, Should CARMENA Really Change our Attitude Towards Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma? A Systematic Review and Meta-Analysis Evaluating Cytoreductive Nephrectomy in the Era of Targeted Therapy., «TARGETED ONCOLOGY», 2018, 13, pp. 705 - 714 [Scientific article]
Massari, Francesco; Ciccarese, Chiara; Hes, Ondrej; Michal, Michal; Caliò, Anna; Fiorentino, Michelangelo; Giunchi, Francesca; D'Amuri, Alessandro; Sanguedolce, Francesca; Sabbatini, Roberto; Guida, Annalisa; Ardizzoni, Andrea; Porta, Camillo; Iacovelli, Roberto; Tortora, Giampaolo; Cima, Luca; Ortega, Cinzia; Lapini, Alberto; Martignoni, Guido; Brunelli, Matteo, The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome, «PATHOLOGY ONCOLOGY RESEARCH», 2018, 24, pp. 447 - 456 [Scientific article]
Massari, Francesco; Ciccarese, Chiara; Hes, Ondrej; Michal, Michal; Caliò, Anna; Fiorentino, Michelangelo; Giunchi, Francesca; D’Amuri, Alessandro; Sanguedolce, Francesca; Sabbatini, Roberto; Guida, Annalisa; Ardizzoni, Andrea; Porta, Camillo; Iacovelli, Roberto; Tortora, Giampaolo; Cima, Luca; Ortega, Cinzia; Lapini, Alberto; Martignoni, Guido; Brunelli, Matteo*, The Tumor Entity Denominated “clear cell-papillary renal cell carcinoma” According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome, «PATHOLOGY ONCOLOGY RESEARCH», 2018, 24, pp. 447 - 456 [Scientific article]
Capizzi, Elisa; Ricci, Costantino; Giunchi, Francesca; Zagnoni, Stefano; Ceccarelli, Claudio; Gómez, Begoña Urrios Álvarez; Casolari, Laura; Gelsomino, Francesco; Trisolini, Rocco; Fiorentino, Michelangelo*; Ardizzoni, Andrea, Validation of the immunohistochemical expression of programmed death ligand 1 (PD-L1) on cytological smears in advanced non small cell lung cancer, «LUNG CANCER», 2018, 126, pp. 9 - 14 [Scientific article]Open Access
Cho, Byoung Chul*; Kim, Dong-Wan; Bearz, Alessandra; Laurie, Scott A.; McKeage, Mark; Borra, Gloria; Park, Keunchil; Kim, Sang-We; Ghosn, Marwan; Ardizzoni, Andrea; Maiello, Evaristo; Greystoke, Alastair; Yu, Richard; Osborne, Karen; Gu, Wen; Scott, Jeffrey W.; Passos, Vanessa Q.; Lau, Yvonne Y.; Wrona, Anna, ASCEND-8: A Randomized Phase 1 Study of Ceritinib, 450 mg or 600 mg, Taken with a Low-Fat Meal versus 750 mg in Fasted State in Patients with Anaplastic Lymphoma Kinase (ALK)-Rearranged Metastatic NonâSmall Cell Lung Cancer (NSCLC), «JOURNAL OF THORACIC ONCOLOGY», 2017, 12, pp. 1357 - 1367 [Scientific article]
Iacovelli, Roberto*; Cossu Rocca, Maria; Galli, Luca; De Giorgi, Ugo; Sabbatini, Roberto; Santoni, Matteo; Mosca, Alessandra; Fornarini, Giuseppe; Massari, Francesco; Masini, Cristina; Bersanelli, Melissa; Biasco, Elisa; Lolli, Cristian; Guida, Annalisa; Berardi, Rossana; Terrone, Carlo; Pastorino, Alessandro; Ardizzoni, Andrea; Pinto, Carmine; Buti, Sebastiano; Nolè, Franco; Tortora, Giampaolo, Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer, «UROLOGIC ONCOLOGY», 2017, 35, pp. 541 - 541.e13 [Scientific article]
Eusebi, Leonardo Henry; Ceccarelli, Claudio; Artesiani, Maria Laura; Montanaro, Lorenzo; Derenzini, Massimo; Dall'Olio, Filippo; Ardizzoni, Andrea; Biasco, Guido; Adua, Daniela; Bazzoli, Franco; Ricciardiello, Luigi, CLINICOPATHOLOGICAL, MOLECULAR AND ONCOLOGICAL FEATURES OF SPORADIC EARLY ONSET COLORECTAL CANCERS, in: Gastroenterology, 2017, 152, pp. S550 - S550 (atti di: Digestive Disease Week, Chicago, USA, MAY 06-09, 2017) [Contribution to conference proceedings]
